Results 171 to 180 of about 131,532 (293)

Group 2 innate lymphoid cells: Where are we 15 years out? [PDF]

J Allergy Clin Immunol
Doherty TA.
europepmc   +1 more source

RORγt‐APCs: The New Masters of Oral Tolerance

Barrier Immunity, EarlyView.
ABSTRACT Oral tolerance is defined by the hypo‐responsiveness of our body to fed antigens, and its failure can lead to immune‐mediated diseases, such as allergy, chronic inflammation and autoimmune diseases. Decades of research have demonstrated that antigen‐presenting cells (APCs) promote oral tolerance by inducing regulatory T cells (Tregs) and/or ...
Thierry Gauthier, WanJun Chen
wiley   +1 more source

Plasticity and antigen presentation by group 3 innate lymphoid cells in colorectal cancer. [PDF]

Front Immunol
Qiao L, Zhang J, Li J, Li X, He X, Zhang M, Lu J, Zhang X, Dong J, Tao G, Wang Y, Cui J, Bao L, Zhao P.   +13 more
europepmc   +1 more source

Commentary: Regulatory Innate Lymphoid Cells Control Innate Intestinal Inflammation

Frontiers in Immunology, 2018
Boning Zeng, Boning Zeng, Shengnan Shi, Jing Liu, Feiyue Xing, Feiyue Xing   +5 more
doaj   +1 more source

Novel Organelle‐Based Intracellular Immunity With Mechanistic and Therapeutic Implications

Barrier Immunity, EarlyView.
A conceptual framework illustrating how PAMPs/DAMPs initiate barrier, innate, adaptive, and intracellular immune responses, with organelle‐based intracellular immunity serving as a central integrator linking metabolism, inflammatory signaling, and therapeutic interventions to restore immune homeostasis.
Keman Xu, Shih‐Yu Hung, Fatma Saaoud, Ying Shao, Yifan Lu, Juanjuan Liu, Bo Yuan, Haiyan Xiang, Hong Wang, Xiaofeng Yang   +9 more
wiley   +1 more source

Heterogeneity and clinical relevance of group 2 innate lymphoid cells subsets in nasal polyps. [PDF]

J Allergy Clin Immunol
Kidoguchi M, Iwasaki N, Poposki JA, Ogasawara N, Oka A, Klingler AI, Suh L, Agrwal A, Bai J, Stevens WW, Peters AT, Grammer LC, Welch KC, Smith SS, Johnson M, Radwan A, Conley DB, Schleimer RP, Kern RC, Tan BK, Okano M, Fujieda S, Kato A.   +22 more
europepmc   +1 more source

Novel Noninvasive Broad‐Spectrum Infrared Treatment of Ulcerative Colitis by Modulating T‐Cell Relocation

ENERGY &ENVIRONMENTAL MATERIALS, EarlyView.
A novel graphene‐based broad‐spectrum infrared (BSIR) device is developed for the noninvasive treatment of ulcerative colitis (UC). BSIR irradiation effectively alleviates colonic inflammation and accelerates mucosal recovery by inducing the systemic relocation of T lymphocytes to the spleen.
Siyu Chen, Jiangtao Zhao, Bohan Jia, Zhigang Ren, Ranran Sun, Liwen Liu, Ding Zhang, Yanqiu Fu, Jia Yu, Shen Shen, Fujun Miao, Zaimei Huang, Ruixia Guo, Peng Zhang, Zujiang Yu, Guosheng Shao   +15 more
wiley   +1 more source

The role of nasal microbiota and type 2 innate lymphoid cells in the pathogenesis of allergic rhinitis. [PDF]

Biochem Biophys Rep
Wang C, Zhang YM, Zhou ML, Li M, Cheng KJ.   +4 more
europepmc   +1 more source

Editorial: Transcriptional and post-transcriptional regulatory networks in cellular homeostasis and stress response

Frontiers in Molecular Biosciences
Alessandra Boccaccini, Davide Capauto, Matteo Cassandri, Silvia Santopolo   +3 more
doaj   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source